SCHEMBL7220970

SCHEMBL7220970

CCOC(=O)c1cccc(-c2nc(-c3ccc(OCC)cc3)cs2)c1

nearest known ligand 0.67

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CDC25A P30304 3/20 0.60
CDC25B P30305 3/20 0.60
CDC25C P30307 3/20 0.60
DUSP3 P51452 3/20 0.60
SREBF2 Q12772 1/20 0.54
MAPT P10636 3/20 0.53
TP53 P04637 2/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
EIF4E P06730 1/20 0.51
POLB P06746 1/20 0.51
MEN1 O00255 1/20 0.49
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
KMT2A Q03164 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
PDE4A P27815 1/20 0.48
PDE4B Q07343 1/20 0.48
PDE4C Q08493 1/20 0.48
PDE4D Q08499 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7215657 0.91 CDC25A (0.60) CDC25ACDC25BCDC25CDUSP3SREBF2
SCHEMBL7217226 0.89 CDC25A (0.62) CDC25ACDC25BCDC25CDUSP3SREBF2
SCHEMBL7214904 0.88 L3MBTL1 (0.61) SREBF2MAPTL3MBTL1EIF4EMEN1
SCHEMBL7221010 0.87 L3MBTL1 (0.54) CDC25ACDC25BCDC25CDUSP3SREBF2
SCHEMBL16180612 0.86 SMN1; SMN2 (0.59) SREBF2MAPTTP53L3MBTL1POLB
SCHEMBL1505172 0.86 L3MBTL1 (0.54) CDC25ACDC25BCDC25CDUSP3SREBF2
SCHEMBL7215066 0.86 L3MBTL1 (0.52) SREBF2MAPTL3MBTL1MEN1NPC1
SCHEMBL23742625 0.84 TRPM8 (0.57) MAPTL3MBTL1EIF4EMEN1KMT2A
SCHEMBL23742629 0.84 KDM4E (0.52) CDC25ACDC25BCDC25CDUSP3MAPT
SCHEMBL10655855 0.81 CDC25A (0.48) CDC25ACDC25BCDC25CDUSP3L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6545009-B1 Imidazole, oxazole and thiazole derivatives for regulation of peroxisome proliferator-activated receptor function; improving insulin resistance, treating impaired glucose tolerance and obesity, enhancing insulin sensitivity, etc. TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-04-08 US disclosed
CN-1314899-A Retinoid-associated receptor regulators TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2001-09-26 CN disclosed
EP-1092711-A1 RETINOID-ASSOCIATED RECEPTOR REGULATORS Takeda Chemical Industries, Ltd. (JP) 2001-04-18 EP disclosed